Retatrutide is a newly developed drug that acts as a strong GLP-1 receptor activator. This innovative approach holds significant potential for regulating type 2 diabetes. By mimicking the actions of natural GLP-1, Retatrutide boosts insulin secretion and reduces glucagon release, leading to improved glucose control. Clinical trials have demonstrate